Producer
Azelis Group
Specialty chemicals & food-ingredients distributor; distributes liquid smoke and smoke flavorings into food manufacturing.
1
Inputs supplied
1
Goods downstream
0
Facilities
0
Stories
What they make
1 input Azelis Group supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Azelis Group makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
Life Sciences — Food & Nutrition
38%Life Sciences — Personal Care & Cosmetics
28%Life Sciences — Pharma & Health
14%Industrial Chemistry
20%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Did you know2020
During the COVID-19 pandemic in 2020, Azelis became an inadvertent allocation authority over competing industries' access to shared chemical inputs. Glycerin (distributed to food manufacturers as a humectant, to pharmaceutical companies as a tablet binder, and to personal care manufacturers as a moisturizer), ethanol (food/flavor manufacturing, pharmaceutical antiseptics, hand sanitizer), and citric acid (food acidulant, pharmaceutical buffer, cleaning agent) all became simultaneously scarce. As a distributor receiving allocations from chemical manufacturers and rationing supply to hundreds of customer industries, Azelis and distributors like it were effectively deciding which industries received priority allocation — food vs. pharma vs. sanitizer vs. cosmetics — without a transparent framework for doing so. The "hidden arbiter" role of specialty chemical distributors during scarcity events is structurally unavoidable: in normal times they are logistical intermediaries, but in shortage conditions they become supply chain gatekeepers across multiple critical industries simultaneously.
Azelis Group ↗Concentration2024
The specialty chemical distribution market — which sits between chemical manufacturers and food, pharma, and industrial end-users — has consolidated into effectively three global platforms: Azelis (~€4B revenue), IMCD (€4.7B), and Brenntag (€16B, focused on commodity/bulk vs. specialty). This distribution oligopoly matters because specialty chemical manufacturers often grant exclusive territorial distribution rights to a single distributor per region, making that distributor's logistics, warehouse, and formulation lab the only commercial channel for that ingredient in that geography. A food manufacturer in Poland needing a specific EU-authorized preservative or emulsifier may have only one authorized distributor with that ingredient in stock in their country. The consolidation that was meant to create supply chain efficiency has instead created single-point-of-failure distribution chokepoints that manufacturers depend on without always recognizing the exposure.
Azelis Group ↗Origin2021
Azelis Group was assembled through over 60 acquisitions since its founding in 2001, consolidating what had been hundreds of regional specialty chemical distributors across Europe, Americas, and Asia-Pacific into a single integrated platform. The specialty chemical distribution industry was historically highly fragmented — each region had local distributors with exclusive supplier relationships and local technical knowledge. Azelis and its peer IMCD (Netherlands) industrialized this fragmentation into scale: their acquisition strategy converted local relationships into a global network while retaining the technical formulation expertise. Azelis listed on Euronext Brussels in September 2021 at a €4.1B valuation, one of the largest European IPOs of that year, backed by private equity firm EQT. By 2023, Azelis had revenues of approximately €4.1B, had expanded to 70+ countries, and had become one of the two largest specialty chemical distributors globally alongside IMCD.
Azelis Group ↗